schizophrenia

Despite significant advances on the discovery front of psychiatric genetics, the clinical value of these advances remains untested and unknown. A primary goal of our lab is to study how we can apply genetic findings to improve clinical care for mental illnesses.

We use biological methods to study genetic risk and mechanisms of clinically important outcomes such as treatment resistance in schizophrenia

Using a data driven driven approach, X-lab aims to identify neurobiologically similar subject groups and symptom profiles